Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
Aug 15, 2022
Jennifer Cabrera, Casey Leaver, Adam Fine and Steve Pemberton are scheduled to speak at New Jersey NECANN in September!
Jun 1, 2022
In VS's inaugural Impact Report, we reflect on our work over the past year, celebrate our commitment to community, and look forward to a future of positive, meaningful, and measurable impact.
Dec 10, 2021
VS Founding Partner Brian Vicente joined TrueGreen's stellar panel at MJBizCon 2021 to discuss the cannabis industry's past and present, and how compliance, technology, and data insights are the future of a successful industry.
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
By Andrew Livingston, Shawn Hauser, Dwight Clark, Mason Tvert
Dec 18, 2020
This VS white paper explains why the current medical marijuana program is falling short and how policymakers can improve patient access, treatment outcomes, and the health of the program. It also explores how such changes would impact the medical cannabis market.
By Andrew Livingston, Shawn Hauser, Dwight Clark, Mason Tvert
Oct 21, 2020
Texas could see more than half a billion dollars in annual tax revenue and tens of thousands of new jobs if it legalizes cannabis, a VS analysis finds.
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.
By Andrew Livingston
Aug 12, 2020
This economic report, produced on behalf of the Marijuana Policy Project, examines the potential tax revenue associated with S.54, the Vermont bill to regulate and tax cannabis sales.